000			01985 a2200577 4500
005			20250517223530.0
264		0	_c20180716
008			201807s 0 0 eng d
022			_a1471-2415
024	7		_a10.1186/s12886-018-0801-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aLai, Kunbei
245	0	0	_aComparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen. _h[electronic resource]
260			_bBMC ophthalmology _cJun 2018
300			_a144 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAngiogenesis Inhibitors _xadministration & dosage
650	0	4	_aChoroid _xblood supply
650	0	4	_aChoroid Diseases _xdiagnosis
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aFluorescein Angiography
650	0	4	_aFollow-Up Studies
650	0	4	_aFundus Oculi
650	0	4	_aHumans
650	0	4	_aIntravitreal Injections
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPhotochemotherapy _xmethods
650	0	4	_aPhotosensitizing Agents _xtherapeutic use
650	0	4	_aPolyps _xdiagnosis
650	0	4	_aPorphyrins _xtherapeutic use
650	0	4	_aProspective Studies
650	0	4	_aRanibizumab _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVerteporfin
650	0	4	_aVisual Acuity
700	1		_aLi, Ying
700	1		_aZhou, Lijun
700	1		_aZhong, Xiaojin
700	1		_aHuang, Chuangxin
700	1		_aXu, Fabao
700	1		_aLu, Lin
700	1		_aGe, Jian
700	1		_aJin, Chenjin
773	0		_tBMC ophthalmology _gvol. 18 _gno. 1 _gp. 144
856	4	0	_uhttps://doi.org/10.1186/s12886-018-0801-7 _zAvailable from publisher's website
999			_c28552560 _d28552560